Morepenlab
Live Price
Recent news and updates for MOREPENLAB will appear here soon.
"Robust technical setup for MOREPENLAB with strong AI conviction. The bullish trend in the healthcare space is accelerating while RSI at 43 suggests there is still significant room for upside before reaching overbought territory."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, NASH/ MASH treatment products, CKD treatment, and anti-depressant drugs; and home diagnostic and point-of-care medical devices products, such as blood glucose monitor and test strips, blood pressure monitors, respiratory devices, ortho support, digital thermometers, digital weighing scale, fertility, nebulizers, pulse oximeters, vaporizers, orthopaedic, stethoscope, and miscellaneous products. It also provides OTC healthcare products; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. In addition, the company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
As of the latest market session, Morepenlab (MOREPENLAB) is trading at ₹113.35, representing a move of -5.00% from the previous close.
Morepenlab is listed and traded under the ticker symbol MOREPENLAB on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Morepenlab's stock price moved by -5.00%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 68% bullish probability for MOREPENLAB stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Morepenlab shares reached a high of ₹150.7 and hit a low of ₹33.05.
MOREPENLAB exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 88,57,838 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Morepenlab has a market capitalization of ₹6211.06 Cr, designating its size class inside the Healthcare sector.
Morepenlab has a current dividend yield of 18.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Morepenlab's trailing Price-to-Earnings (P/E) ratio is 33.05. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Morepenlab (MOREPENLAB) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Morepenlab's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore MOREPENLAB's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for MOREPENLAB are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Morepenlab operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.